Immunotherapy vs inhaled budesonide in bronchial asthma: An open, parallel, comparative trial

Clinical and Experimental Allergy

Volumn 27, Issue 11, 1997, Pages 1279-1284

  Shaikh, W A ^a,b  

^a BOMBAY HOSPITAL   (India)

^b Shakti Sadan Co op Housing Society   (India)

Author keywords

Asthma; Budesonide; Corticosteroid; Immunotherapy

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; HOUSE DUST ALLERGEN; SALBUTAMOL; VACCINE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DESENSITIZATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030664306     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01172.x     Document Type: Article

References (42)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; i:1572-3.
2. Bousquet J, Hejjaoui A, Clauzel AM et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82:971-7.
3. Mosbech H, Weeke B. Immunotherapy in the treatment of asthma. Clin Allergy 1986; 16:10-17.
4. Mosbech H, Dreborg S, Frolund L et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by diary cards and a retrospective assessment. Allergy 1989; 44:487-98.
5. Ohman JL. Allergen immunotherapy in asthma: evidence for efficacy. J Allergy Clin Immunol 1989; 84:133-40.
6. Committee on safety of Medicines. CSM update: desensitizing vaccines. Br Med J 1986; 293:948.
7. Grant IWB. Does immunotherapy have a role in the treatment of asthma? Clin Allergy 1986; 16:17-16.
8. Van Essen-Zandvliet EEM, Hughes MD, Waalkens HJ et al. Effects of 22 months treatment with inhaled corticosteroid and/ or beta-2 agonist on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992; 146:547-54.
9. Woolcock AJ, Yan K, Salome CM et al. Effect of therapy on bronchial hyperresponsiveness in long-term management of asthma. Clin Allergy 1988; 18:165-76.
10. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non steroid-dependent asthmatics. Am Rev Respir Dis 1990; 142:832-6.
11. Haahtela T, Jarvinnen M, Kava T et al. Comparison of a beta-2 agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Eng J Med 1991; 325:388-92.
12. International Consensus report on diagnosis and treatment of asthma. National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Publication No. 92-3091, June 1992.
13. Hassard TH. Understanding biostatistics. St. Louis: Mosby year book, 1991: A-11.
14. Shaikh WA. Allergy: an Indian perspective. In Shaikh WA (Ed). Speciality issue on Asthma and Allergy, Ind J Clin Pract July 1994:19-26.
15. Turkeltaub PC. The allergy unit - clinical relevance: Issues in allergen standardization. In Lockey RF, Bukantz SC (Eds). Allergen Immunotherapy, New York: Marcel Dekker Inc., 1991:171-90.
16. Van Metre TE Jr., Adkinson NF Jr., Immunotherapy for aeroallergen disease. In Middleton E Jr., Reed CE, Ellis EF, Adkinson NF Jr., Yunginger JW (Eds). Allergy - Principles and Practice. 3rd edn., St. Louis: C.V. Mosby, 1988:1337.
17. Malling HJ, Weeke B. (Eds). EAACI Immunotherapy Position Paper. Allergy 1993; 48 suppl. 14:9-36.
18. Valovirta E, Koivikko A, Vanto T, Viander M, Ingeman L. Immunotherapy in allergy to dog: a double blind clinical study. Ann Allergy 1984; 53:85-8.
19. Sundin B, Lilja G, Graff-Lonnevig V, Hedlin G, Heilborn H, Norrlind K, Pegelow K-O, Lowenstein H. Immunotherapy with partially purified and standardized animal dander extracts. I. J Allergy Clin Immunol 1986; 77:478-87.
20. Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, Pegelow K-O, Sundin B. Immunotherapy with cat- and dog-dander extracts II. J Allergy Clin Immunol 77:488-96.
21. Valovirta E, Viander M, Koivikko A, Vanto T, Ingeman L. Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study. Ann Allergy 1986; 57:173-9.
22. Van Metre TE, Marsh DG, Adkinson NF et al. Immunotherapy for cat asthma. J Allergy Clin Immunol 1988; 82:1055-68.
23. Van Metre TE, Marsh DG, Adkinson NF, Kagey-Sobotka AK, Khattignavong A, Norman PS, Rosenberg GL. Immunotherapy decreases skin sensitivity to cat extract. J Allergy Clin Immunol 1989; 83:888-99.
24. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Doubleblind, placebo controlled immunotherapy with mixed grass-pollen allergoids IV. Comparison of the safety and efficacy. J Allergy Clin Immunol 1990; 85:490-7.
25. Horst M, Hejjaoui A, Horst V et al. Double-blind, placebo controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990; 85:460-72.
26. D'Souza MF, Pepys J, Wells ID et al. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunologic effects. Clin Allergy 1973; 3:177.
27. Pence HL, Mitchell DQ, Greely RL, Updegraff BR, Selfridge HA. Immunotherapy for mountain cedar pollinosis. J Allergy Clin Immunol 1976; 58:39-50.
28. Gaddie J, Skinner PC, Palmer KNV. Hyposensitization with house dust mite vaccine in bronchial asthma. Br Med J 1976; 2:561.
29. Gabriel M, Allen W, Hill LE, Nunn AJ. Study of prolonged hyposensitization with D. Pteronyssinus extract in allergic rhinitis. Clin Allergy 1977; 7:325-36.
30. Van Metre TE, Adkinson NF, Amodio FJ et al. A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed hay fever. J Allergy Clin Immunol 1979; 66:500-13.
31. Dreborg S, Agrell B, Foucard T et al. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986; 41:131-40.
32. Karlsson R, Agrell B, Dreborg S et al. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results. Allergy 1986; 41:141-50.
33. Bousquet J, Clauzel AM, Hejjaoui A et al. Non-specific bronchial reactivity in asthmatic subjects after immunotherapy with a standardized mite extract. Am Rev Respir Dia 1987; 135:A135.
34. Mosbech H, Dreborg S. Frolund L et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by challenges with allergen and histamine. Allergy 1989; 44:499-509.
35. Murray AB, Fergusson AC, Morrison BJ. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. Ann Allergy 1985; 54:541-4.
36. Torres Costa JC, Placodi JL, Morreira Silva JP, Delgado L, Vaz M. Effects of immunotherapy on symptoms, PEFR, spirometry and airway responsiveness in patients with allergic asthma to house dust mites (D. Pteronyssinus) on inhaled steroid therapy. Allergy 1996; 51:238-44.
37. Kraan J, Koeter GH, Van der Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76:628-36.
38. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991; 143:1317-21.
39. Bel EH, Timmers MC, Zwinderman AH, Djikman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 1991; 143:109-13.
40. Magnussen H, Willenbrock U, Jorres R. Airway responsiveness, lung function and symptoms after cessation of high dose inhaled corticosteroids in patients with bronchial asthma. Am Rev Respir Dis 1992; 145:A498.
41. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD et al. Cessation of long term treatment with inhaled corticosteroid (budesonide) in children with asthma, results in deterioration. Am Rev Respir Dis 1993; 148:1252-7.
42. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave EF. Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87:483-9.